Psyence Biomedical Ltd. (PBMWW)Toronto, Canada | NasdaqCM
0.05 USD
+0.05
(0.000%)
⇧
(April 20, 2026, 3:59 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:47 a.m. EDT
Psyence Biomedical Ltd. (PBMWW) presents a classic value trap with deteriorating fundamentals: negative ROE/-40% ROA, bleeding cash flows, and a stagnant price action at 52-week lows with zero momentum. Combined with virtually no dividend yield and no analyst coverage, the risk/reward profile is strongly bearish for both short-term trades and long-term holds. |
| Attribute | Value |
|---|---|
| Beta | 0.31 |
| Previous Name | Psyence Therapeutics Corp. |
| Website | https://www.psyencebiomed.com |
| Attribute | Value |
|---|---|
| Address1 | 121 Richmond Street West |
| Address2 | Penthouse Suite, 1300 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.306 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 39.619 |
| City | Toronto |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.045 |
| Current Ratio | 8.09 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.06 |
| Day Low | 0.0344 |
| Display Name | Psyence Biomedical |
| Ebitda | -4,145,455 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.06 |
| Fifty Two Week High Change | -0.014999997 |
| Fifty Two Week High Change Percent | -0.24999996 |
| Fifty Two Week Low | 0.0344 |
| Fifty Two Week Low Change | 0.010600001 |
| Fifty Two Week Low Change Percent | 0.30813953 |
| Fifty Two Week Range | 0.0344 - 0.06 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 292,594 |
| Free Cashflow | -4,006,023 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,024-01-26 |
| Language | en-US |
| Long Business Summary | Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc. |
| Long Name | Psyence Biomedical Ltd. |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_698500412 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -3,941,597 |
| Open | 0.024 |
| Operating Cashflow | -4,247,508 |
| Operating Margins | 0.0 |
| Phone | 416 346 7764 |
| Prev Name | Psyence Therapeutics Corp. |
| Previous Close | 0.0 |
| Price Hint | 4 |
| Price To Book | 0.0011358188 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.766 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.045 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.06 |
| Regular Market Day Low | 0.0344 |
| Regular Market Day Range | 0.0344 - 0.06 |
| Regular Market Open | 0.024 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 0.045 |
| Regular Market Time | 1,776,715,190 |
| Regular Market Volume | 1,775,298 |
| Return On Assets | -0.34442002 |
| Return On Equity | -0.74286 |
| Sand P52 Week Change | 0.34445214 |
| Sector | |
| Sector Key | |
| Short Name | Psyence Biomedical Ltd. Warrant |
| Source Interval | 15 |
| State | ON |
| Symbol | PBMWW |
| Total Cash | 7,149,985 |
| Total Cash Per Share | 23.871 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 1,775,298 |
| Website | https://www.psyencebiomed.com |
| Zip | M5H2K1 |